Literature DB >> 1761517

The existence of galactosylceramide I3-sulfate in serums of various mammals and its anticoagulant activity.

X H Zhu1, A Hara, T Taketomi.   

Abstract

Human, porcine, goat, sheep, bovine, horse, canine, rat, mouse, guinea pig, and chicken serums were investigated for the existence of sulfatide. Among the ten mammal serums, seven were found to be sulfatide positive, and the amounts of sulfatide were determined to be: 16.29 nmol/ml serum (porcine), 9.39 (bovine), 12.71 (goat), 7.75 (horse), 1.21 (sheep), 0.64 (human), and 0.16 (dog). The existence of sulfatide in the serums of human, goat, sheep, cow, horse, and dog is here reported for the first time. It is suggested that sulfatide is widely distributed in the serums of various mammals except for rodents and that it takes part in the anticoagulant systems. The fatty acids of those sulfatides comprised mainly non-hydroxy fatty acids and a significant amount (18-53% of the total fatty acid) of hydroxy fatty acids with chain lengths of C16, C22, C23, and C24. The long chain bases comprised sphingenine, sphinganine, and 4-D-hydroxysphinganine. Experiments to elucidate the mechanism of the anticoagulant activity of sulfatide revealed that it was specific to sulfatide and that the galactose-bound sulfate group is essential for this activity. The activity of clusters of sulfatide molecules was much more pronounced than that of single molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1761517     DOI: 10.1093/oxfordjournals.jbchem.a123564

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

Review 1.  Implication of GnT-V in cancer metastasis: a glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor.

Authors:  N Taniguchi; S Ihara; T Saito; E Miyoshi; Y Ikeda; K Honke
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model.

Authors:  M Kyogashima; J Onaya; A Hara; T Taketomi
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

3.  Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.

Authors:  Yuji Kamijo; Lixuan Wang; Akihiro Matsumoto; Takero Nakajima; Koji Hashimoto; Makoto Higuchi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Clin Exp Nephrol       Date:  2012-05-03       Impact factor: 2.801

4.  Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patients via processes correlated to oxidative stress and platelet count.

Authors:  Lixuan Wang; Yuji Kamijo; Akihiro Matsumoto; Takero Nakajima; Makoto Higuchi; Reiji Kannagi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Glycoconj J       Date:  2011-04-19       Impact factor: 2.916

5.  Roles of galactose and sulfate residues in sulfatides for their antagonistic functions in the blood coagulation system.

Authors:  M Kyogashima; T Sakai; J Onaya; A Hara
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

6.  Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure.

Authors:  Rui Hu; Gang Li; Yuji Kamijo; Toshifumi Aoyama; Takero Nakajima; Teruo Inoue; Koichi Node; Reiji Kannagi; Mamoru Kyogashima; Atsushi Hara
Journal:  Glycoconj J       Date:  2007-07-27       Impact factor: 2.916

7.  Sulfatide prolongs blood-coagulation time and bleeding time by forming a complex with fibrinogen.

Authors:  A Hara; K Uemura; T Taketomi
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

8.  Sulfatides are endogenous ligands for the TLR4-MD-2 complex.

Authors:  Lijing Su; Muhammad Athamna; Ying Wang; Junmei Wang; Marina Freudenberg; Tao Yue; Jianhui Wang; Eva Marie Y Moresco; Haoming He; Tsaffrir Zor; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.